Clinical problem | Intervention | Comments |
All patients with EIB | Educate about features of exercise that are likely to provoke EIB (eg, effect of temperature, dry air, intensity of exertion, allergens, pollution) and measures for mitigation | |
Educate about use of SABA to treat EIB symptoms (eg, albuterol 2 puffs) | ||
Educate about use of SABA or other agent to prevent EIB | ||
Advise caution about vigorous exercise when asthma is poorly controlled | ||
Patients intolerant of SABA | Try 1 puff of albuterol instead of 2 | May not provide adequate prevention of EIB symptoms. |
Review inhaler technique and consider use of spacer/chamber | ||
Improve general control of asthma (eg, with inhaled glucocorticoid) to reduce need for prophylaxis | If asthma not well controlled (based on frequency/severity of symptoms or need for rescue inhaler, low peak flow or FEV1), add inhaled glucocorticoid. If asthma is otherwise well controlled, try alternate preventive agents. | |
Try alternate SABA (eg, levalbuterol)* | Try levalbuterol if above interventions are unsuccessful and levalbuterol is available. Levalbuterol can also be used for breakthrough symptoms. May not completely eliminate adverse effects of SABA. | |
Try regular use of LTRA*¶Δ | LTRA may be more effective in children than adults. | |
Try ipratropium 2 puffs, 20 to 30 minutes prior to exercise*Δ | ||
Substitute cromolyn or nedocromil (where available) for SABA for prophylaxis*Δ | ||
EIB refractory to SABA | Add regular use of LTRA | |
Improve general control of asthma (eg, with inhaled glucocorticoid) | ||
Use cromoglycate with SABA as prophylaxis (where available) | ||
Reassess diagnosis | ||
Patients who exercise for more than 3 hours or more than once per day | Avoid LABA monotherapy or daily use of SABA | Tachyphylaxis may occur with daily SABA or LABA. |
Try LTRA | May be more effective for prevention of EIB in children than adults. | |
Improve general control of asthma (eg, with inhaled glucocorticoid) | ||
Patients who exercise in extreme conditions (eg, high intensity or in dry, cold air) | Try methods for mitigation (eg, warm-up, scarf or face mask), depending on setting | |
Empiric trial of combination albuterol-ipratropium 20 to 30 minutes prior to exercise |
FEV1: forced expiratory volume in 1 second; LABA: long-acting beta agonist; LTRA: leukotriene receptor antagonist; SABA: short-acting beta agonist.
* Choice between levalbuterol, LTRA, ipratropium, and cromoglycate is based on drug availability and patient/clinician preference.
¶ LTRA must be taken at least 2 hours prior to exercise if used episodically.
Δ Patient will still need to have a SABA inhaler available for treatment of breakthrough symptoms.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟